Within 30 days prior to admission, the ALR shall consult with the prospective resident’s healthcare practitioner regarding:
(1) The prospective resident’s current medication profile, including a review of nonprescription drugs;
(2) Possible adverse interactions;
(3) Common expected or unexpected side effects; and
(4) The potential that such medications have to act as chemical restraints.